BRCA1, BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer

被引:1
|
作者
Shehaj, Ina [1 ]
Krajnak, Slavomir [1 ]
Almstedt, Katrin [1 ]
Degirmenci, Yaman [1 ]
Herzog, Sophia [1 ]
Lebrecht, Antje [1 ]
Linz, Valerie Catherine [1 ]
Schwab, Roxana [1 ]
Stewen, Kathrin [1 ]
Brenner, Walburgis [1 ]
Hasenburg, Annette [1 ]
Schmidt, Marcus [1 ]
Heimes, Anne-Sophie [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Obstet & Gynecol, D-55131 Mainz, Germany
关键词
mRNA expression; BRCA1; BRCA2; PALB2; metagene; breast cancer; HETEROGENEITY; PROTEIN; IMPACT;
D O I
10.3390/biomedicines12061361
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Breast cancer (BC) poses a challenge in establishing new treatment strategies and identifying new prognostic and predictive markers due to the extensive genetic heterogeneity of BC. Very few studies have investigated the impact of mRNA expression of these genes on the survival of BC patients. Methods: We examined the impact of the mRNA expression of breast cancer gene type 1 (BRCA1), breast cancer gene type 2 (BRCA2), and partner and localizer of BRCA2 (PALB2) on the metastasis-free survival (MFS) of patients with early BC using microarray gene expression analysis. Results: The study was performed in a cohort of 461 patients with a median age of 62 years at initial diagnosis. The median follow-up time was 147 months. We could show that the lower expression of BRCA1 and BRCA2 is significantly associated with longer MFS (p < 0.050). On the contrary, the lower expression of PALB2 was correlated with a shorter MFS (p = 0.049). Subgroup survival analysis identified the prognostic influence of mRNA expression for BRCA1 among patients with luminal-B-like BC and for BRCA2 and PALB2 in the subset of patients with luminal-A-like BC (p < 0.050). Conclusions: According to our observations, BRCA1, BRCA2, and PALB2 expression might become valuable biomarkers of disease progression.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] BRCA1 and BRCA2 in breast cancer
    Xiaohong Yang
    Marc E. Lippman
    Breast Cancer Research and Treatment, 1999, 54 : 1 - 10
  • [22] PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response
    Srilatha Simhadri
    Gabriele Vincelli
    Yanying Huo
    Sarah Misenko
    Tzeh Keong Foo
    Johanna Ahlskog
    Claus S. Sørensen
    Gregory G. Oakley
    Shridar Ganesan
    Samuel F. Bunting
    Bing Xia
    Oncogene, 2019, 38 : 1585 - 1596
  • [23] BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study
    Zhen, David B.
    Rabe, Kari G.
    Gallinger, Steven
    Syngal, Sapna
    Schwartz, Ann G.
    Goggins, Michael G.
    Hruban, Ralph H.
    Cote, Michele L.
    McWilliams, Robert R.
    Roberts, Nicholas J.
    Cannon-Albright, Lisa A.
    Li, Donghui
    Moyes, Kelsey
    Wenstrup, Richard J.
    Hartman, Anne-Renee
    Seminara, Daniela
    Klein, Alison P.
    Petersen, Gloria M.
    GENETICS IN MEDICINE, 2015, 17 (07) : 569 - 577
  • [24] PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response
    Simhadri, Srilatha
    Vincelli, Gabriele
    Huo, Yanying
    Misenko, Sarah
    Foo, Tzeh Keong
    Ahlskog, Johanna
    Sorensen, Claus S.
    Oakley, Gregory G.
    Ganesan, Shridar
    Bunting, Samuel F.
    Xia, Bing
    ONCOGENE, 2019, 38 (10) : 1585 - 1596
  • [25] BRCA1 and BRCA2 in Indian Breast Cancer Patients
    Saxena, Sunita
    Szabo, Csilla I.
    Chopin, Sandrine
    Barjhoux, Laure
    Sinilnikova, Olga
    Lenoir, Gilbert
    Goldgar, David E.
    Bhatanager, Dinesh
    HUMAN MUTATION, 2002, 20 (06) : 473 - 474
  • [26] Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases
    Blanco, Ana
    de la Hoya, Miguel
    Osorio, Ana
    Diez, Orland
    Dolores Miramar, Maria
    Infante, Mar
    Martinez-Bouzas, Cristina
    Torres, Asuncion
    Lasa, Adriana
    Llort, Gemma
    Brunet, Joan
    Grana, Begona
    Perez Segura, Pedro
    Jose Garcia, Maria
    Gutierrez-Enriquez, Sara
    Carracedo, Angel
    Tejada, Maria-Isabel
    Velasco, Eladio A.
    Calvo, Maria-Teresa
    Balmana, Judith
    Benitez, Javier
    Caldes, Trinidad
    Vega, Ana
    PLOS ONE, 2013, 8 (07):
  • [27] BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients
    Rogozinska-Szczepka, J
    Utracka-Hutka, B
    Grzybowska, E
    Maka, B
    Nowicka, E
    Smok-Ragankiewicz, A
    Zientek, H
    Steffen, J
    Wojciechowska-Lacka, A
    ANNALS OF ONCOLOGY, 2004, 15 (09) : 1373 - 1376
  • [28] Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus
    Sokolenko, Anna P.
    Bakaeva, Elvina Kh.
    Venina, Aigul R.
    Kuligina, Ekaterina Sh.
    Romanko, Alexandr A.
    Aleksakhina, Svetlana N.
    Belysheva, Yana V.
    Belogubova, Evgeniya V.
    Stepanov, Ilya A.
    Zaitseva, Olga A.
    Yatsuk, Olga S.
    Togo, Alexandr V.
    Khamgokov, Zaur M.
    Kadyrova, Azinat O.
    Pirmagomedov, Albert Sh.
    Bolieva, Marina B.
    Epkhiev, Alexandr A.
    Tsutsaev, Aslan K.
    Chakhieva, Madina D.
    Khabrieva, Khalimat M.
    Khabriev, Idris M.
    Murachuev, Mirza A.
    Buttaeva, Bella N.
    Baboshkina, Liliya S.
    Bayramkulova, Fatima I.
    Katchiev, Islam R.
    Alieva, Lina Kh.
    Raskin, Grigory A.
    Orlov, Sergey V.
    Khachmamuk, Zarema K.
    Levonyan, Karine R.
    Gichko, Dariya M.
    Kirtbaya, Dmitriy V.
    Degtyariov, Alexey M.
    Sultanova, Luisa V.
    Musayeva, Hedi S.
    Belyaev, Alexey M.
    Imyanitov, Evgeny N.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (02) : 307 - 315
  • [29] Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus
    Anna P. Sokolenko
    Elvina Kh. Bakaeva
    Aigul R. Venina
    Ekaterina Sh. Kuligina
    Alexandr A. Romanko
    Svetlana N. Aleksakhina
    Yana V. Belysheva
    Evgeniya V. Belogubova
    Ilya A. Stepanov
    Olga A. Zaitseva
    Olga S. Yatsuk
    Alexandr V. Togo
    Zaur M. Khamgokov
    Azinat O. Kadyrova
    Albert Sh. Pirmagomedov
    Marina B. Bolieva
    Alexandr A. Epkhiev
    Aslan K. Tsutsaev
    Madina D. Chakhieva
    Khalimat M. Khabrieva
    Idris M. Khabriev
    Mirza A. Murachuev
    Bella N. Buttaeva
    Liliya S. Baboshkina
    Fatima I. Bayramkulova
    Islam R. Katchiev
    Lina Kh. Alieva
    Grigory A. Raskin
    Sergey V. Orlov
    Zarema K. Khachmamuk
    Karine R. Levonyan
    Dariya M. Gichko
    Dmitriy V. Kirtbaya
    Alexey M. Degtyariov
    Luisa V. Sultanova
    Hedi S. Musayeva
    Alexey M. Belyaev
    Evgeny N. Imyanitov
    Breast Cancer Research and Treatment, 2024, 203 : 307 - 315
  • [30] BRCA1 and PALB2 in a Messy Breakup
    Her, Joonyoung
    Bunting, Samuel F.
    CANCER RESEARCH, 2020, 80 (19) : 4044 - 4045